Cipla (CIPLA) Q4 14/15 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 14/15 earnings summary
15 Oct, 2026Executive summary
FY 2014-15 consolidated revenue reached ₹11,345 crore, up 11.5% YoY; profit for the year fell 15% to ₹1,181 crore amid mix changes and higher R&D and talent investment.
Corrective actions supported robust Q4 revenue momentum, with management expecting that momentum to continue into FY 2015-16.
The year focused on strengthening operations, expanding global market presence, and investing in product development and capabilities.
Financial highlights
Consolidated revenue from operations was ₹11,345.44 crore versus ₹10,173.39 crore in FY 2013-14; consolidated PBT was ₹1,654.25 crore versus ₹1,880.04 crore.
Consolidated profit for the year was ₹1,180.77 crore versus ₹1,388.41 crore; basic EPS was ₹14.71 versus ₹17.29 and diluted EPS ₹14.66 versus ₹17.27.
Consolidated EBITDA was ₹2,162 crore, with a 19.1% FY 2014-15 EBITDA margin, supported by price/mix, licensing deals and cost management.
Domestic business revenue rose 18% to ₹4,825 crore; exports increased 5.6% to ₹6,058 crore.
Outlook and guidance
Management expected Q4 FY 2014-15 growth momentum to continue in FY 2015-16 and prioritized delivery of financial commitments, pipeline launches and growth strategies.
More than 80% of critical launches were on track; priorities included strengthening manufacturing, supply chain and procurement, integrating signed deals, and simplifying processes and systems.
Over 200 development projects were in progress; more than 70 products were added to the API pipeline, with effects from the new portfolio expected from 2017.
Latest events from Cipla
- FY18 margins expanded and PAT rose 40%, despite US pricing and launch headwinds.CIPLA
Q4 17/18 - Revenue grew 12%, while record margins and cash generation strengthened FY21 performance.CIPLA
Q4 20/21 - Record FY22 revenue, with growth led by India, North America and SAGA.CIPLA
Q4 21/22 - Record revenue and EBITDA, led by India and North America, amid regulatory and pricing risks.CIPLA
Q4 22/23 - Revenue rose 8% as core markets lifted EBITDA margin to 19.4%.CIPLA
Q4 18/19 - Core-market growth lifted FY17, but impairments and market pressures constrained reported results.CIPLA
Q4 16/17 - Revenue topped ₹10,000 crore, but profit declined as investment and mix pressured margins.CIPLA
Q4 13/14 - Record PAT and stronger cash flow offset COVID-19, pricing and regulatory headwinds.CIPLA
Q4 19/20 - FY16 growth accelerated, while acquisition debt and pricing litigation raised risks.CIPLA
Q4 15/16